![]() |
市场调查报告书
商品编码
1800842
2025 年至 2033 年颅内压监测市场报告(按产品类型、技术、监测类型、应用、最终用户和地区)Intracranial Pressure Monitoring Market Report by Product Type, Technology, Monitoring Type, Application, End-User, and Region 2025-2033 |
2024年,全球颅内压监测市场规模达19亿美元。展望未来, IMARC Group预计到2033年,该市场规模将达到31亿美元,2025-2033年期间的复合年增长率(CAGR)为5.47%。创伤性脑损伤发病率的上升、神经系统疾病的增加、中风盛行率的上升、监测技术的进步、早期诊断意识的增强以及改善患者预后的需求是推动市场成长的一些主要因素。
神经系统疾病盛行率不断上升
脑外伤、中风、脑积水和其他神经系统疾病等发生率不断上升,需要有效的监测解决方案,这也增加了对 ICP 监测设备的需求。根据美国国立卫生研究院 (NIH) 估计,印度每年有近 150 万至 200 万人受伤,100 万人死亡。道路交通伤害是脑外伤的主要原因(60%),其次是跌倒(20%-25%)和暴力(10%)。已知 15%-20% 的脑外伤患者在受伤时与酒精有关。根据美国疾病管制与预防中心 (CDC) 的数据,估计每年有 250 万人遭受脑部外伤 (TBI)。脑损伤最常见于 15 至 24 岁的男性。 5 岁以下的儿童和 75 岁以上的老年人脑损伤的发生率也很高。预计预测期内颅内压监测市场收入将进一步增加。
医疗科技的重大进步
监测技术的不断创新,包括微创和非侵入性颅内压(ICP)监测技术的开发,提高了这些设备的准确性、安全性和易用性,推动了市场成长。例如,2024年6月,发表在《自然》杂誌上的一篇研究文章中,一个中国研究团队发明了一种微型可注射超音波感测器,用于无线监测颅内讯号,从而提供了一种超越当前临床仪器局限性的选择。根据这项研究,这些感测器是8立方毫米大小的立方体,由可生物降解、刺激响应的水凝胶和週期性排列的气柱製成,具有特定的声学反射频谱。透过穿刺针植入颅内后,这些装置可以根据生理环境变化而变形,导致反射超音波的峰值频率发生偏移,可以透过外部超音波探头进行无线测量。这些重大进展正在为全球颅内压监测市场带来积极的前景。
提高认识和早期诊断
医疗服务提供者和患者越来越意识到早期诊断和干预脑部疾病的重要性,这推动了对颅内压 (ICP) 监测系统的需求。例如,2024 年 3 月,伦敦国王学院 (KCL) 的研究人员开发了一个深度学习框架,用于开发一种非侵入式脑年龄预测工具,用于神经系统疾病的早期诊断。该研究在训练了来自多种磁振造影 (MRI) 类型的多个脑部模型后,建构并提供了一套可供临床使用的模型。阿兹海默症、中风、多发性硬化症和帕金森氏症等神经系统疾病不仅影响大脑,也会影响人体各处的神经和脊髓。这些进展对于疾病的早期诊断至关重要,再加上人们对早期疾病诊断重要性的认识不断提高,预计将对颅内压监测市场预测产生积极影响。
显示器占据大部分市场份额
市场对监视器的需求源于创伤性脑损伤、中风和神经系统疾病的日益增长,这些疾病需要精确且持续的监测。医疗技术的进步,包括非侵入性和微创监视器的出现,提高了患者的安全性和舒适度,从而促进了监视器的普及。人们对脑部疾病早期诊断和介入的认识日益提高,加上医疗基础设施的改善和医疗支出的增加(尤其是在已开发地区),进一步推动了颅内压监测的需求。
Invasive 占据业界最大份额
市场对侵入式技术的需求源自于其在重症监护环境中的高精度和可靠性。侵入式技术引领了颅内压监测市场许多最新发展,对于治疗严重创伤性脑损伤、脑积水和其他需要精确压力测量的神经系统疾病至关重要。此外,侵入式监测设备的进步提高了安全性和易用性,进一步提升了其应用。能够提供对及时临床干预至关重要的持续即时资料,也推动了对侵入式颅内压监测技术的需求,从而在全球范围内创造了积极的市场前景。
心室内代表领先的细分市场
市场对脑室内监测的需求源于其卓越的精度以及监测和引流脑脊髓液 (CSF) 的能力,这对于治疗重症创伤性脑损伤和脑积水至关重要。该方法提供持续、即时的压力资料和治疗干预能力,对重症监护至关重要。此外,神经系统疾病盛行率的不断上升以及重症监护病房对精准颅内压管理的需求进一步推动了脑室内监测的需求。
创伤性脑损伤在市场上占据明显主导地位
创伤性脑损伤 (TBI) 患者对颅内压 (ICP) 监测的需求源于对精准即时压力资料的需求,以预防继发性脑损伤。早期准确的颅内压监测对于指导治疗决策、降低死亡率和改善患者预后至关重要。 TBI 发生率高,尤其由事故和运动伤害引起,加之监测技术的进步和医疗服务提供者意识的提高,进一步推动了该领域对颅内压监测的需求。
医院占据市场主导地位
医院对颅内压 (ICP) 监测的需求源于创伤性脑损伤、中风以及需要重症监护的神经系统疾病的高发性。医院配备了先进的医疗基础设施和能够有效运用 ICP 监测技术的专业人员。对早期诊断和介入的重视,加上加护病房对持续、精准监测的需求,进一步刺激了颅内压监测的需求。此外,医院整合 ICP 监测最新进展的能力,可确保患者获得更佳治疗效果,并推动颅内压监测市场的成长。
北美引领市场,占据最大的颅内压监测市场份额
该报告还对所有主要区域市场进行了全面分析,包括北美(美国和加拿大);欧洲(德国、法国、英国、义大利、西班牙、俄罗斯等);亚太地区(中国、日本、印度、韩国、澳洲、印尼等);拉丁美洲(巴西、墨西哥等);以及中东和非洲。报告指出,北美是颅内压监测最大的区域市场。
在北美,颅内压监测市场受到创伤性脑损伤和神经系统疾病高发生率、先进的医疗基础设施以及巨额医疗支出的驱动。根据宾州大学的一项研究,每年约有200万美国人遭受某种形式的创伤性脑损伤。在美国,每15秒就有一人(通常是年轻人)遭受脑损伤。每年约有10万人死于创伤性脑损伤 (TBI),另有50万人永久残疾。每年有8万人在严重脑损伤后出现长期残疾。约有530万美国人(超过美国人口的2%)患有由TBI导致的残疾。美国每年用于治疗、復健和护理创伤性脑损伤患者的费用约为300亿美元。该地区大力采用创新医疗技术,并不断提高对脑相关疾病早期诊断和干预的认识,进一步刺激了该领域的需求。此外,领先的医疗器材製造商的存在和持续的研究和开发活动促进了北美市场的成长。
(请注意,这只是关键参与者的部分列表,完整列表在报告中提供。)
The global intracranial pressure monitoring market size reached USD 1.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.1 Billion by 2033, exhibiting a growth rate (CAGR) of 5.47% during 2025-2033. The increasing incidences of traumatic brain injuries, growing neurological disorders, rising prevalence of strokes, advancements in monitoring technology, growing awareness of early diagnosis, and the need for improved patient outcomes are some of the major factors propelling the market growth.
Increasing Prevalence of Neurological Disorders
The rising incidence of conditions such as traumatic brain injuries, strokes, hydrocephalus, and other neurological disorders necessitates effective monitoring solutions, boosting the demand for ICP monitoring devices. According to The National Institute of Health (NIH), it is estimated that nearly 1.5 to 2 million persons are injured and 1 million succumb to death every year in India. Road traffic injuries are the leading cause (60%) of traumatic brain injuries followed by falls (20%-25%) and violence (10%). Alcohol involvement is known to be present among 15%-20% of traumatic brain injuries at the time of injury. According to the Centers for Disease Control and Prevention (CDC), an estimated 2.5 million people sustain a traumatic brain injury (TBI) each year. Brain injuries are most common in men between the ages of 15 to 24. Children under the age of 5 and older adults over age 75 also have a high incidence of brain injury. This is further projected to increase the intracranial pressure monitoring market revenue during the forecast period.
Significant Advancements in Medical Technology
The rising innovations in monitoring technology, including the development of minimally invasive and non-invasive ICP monitoring techniques, have improved the accuracy, safety, and ease of use of these devices, driving market growth. For instance, in June 2024, as published in a research article in Nature journal, a Chinese research team created a mini-injectable ultrasonic sensor for wireless monitoring of intracranial signals, thereby providing an option that goes beyond the limitations of current clinical instruments. According to the study, the sensors are cubes that are eight cubic millimeters in size, and they are made from biodegradable and stimulus-responsive hydrogels and periodically aligned air columns with a specific acoustic reflection spectrum. Implanted into intracranial space with a puncture needle, the devices can deform in response to physiological environmental changes, resulting in peak frequency shifts of reflected ultrasound waves that can be wirelessly measured by an external ultrasound probe. Such significant advancements are creating a positive intracranial pressure monitoring market outlook across the globe.
Growing Awareness and Early Diagnosis
Increased awareness about the importance of early diagnosis and intervention for brain-related conditions among healthcare providers and patients fuels the demand for ICP monitoring systems. For instance, in March 2024, researchers from King's College London (KCL) developed a deep learning framework for a non-invasive brain-age prediction tool for the early diagnosis of neurological diseases. The study built and made available a set of models for clinical use after training multiple brain models from a variety of magnetic resonance image (MRI) types. Neurological disorders, such as Alzheimer's disease, strokes, multiple sclerosis, and Parkinson's disease, are conditions that affect the brain as well as the nerves found throughout the human body and spinal cord. Advancements like these are pivotal to the early diagnosis of the diseases, which, when coupled with the rising awareness regarding the significance of the early disease diagnosis, are expected to have a positive impact on the intracranial pressure monitoring market forecast.
Monitors accounts for the majority of the market share
The demand for monitors in the market is driven by the increasing prevalence of traumatic brain injuries, strokes, and neurological disorders, necessitating accurate and continuous monitoring. Advancements in medical technology, including non-invasive and minimally invasive monitors, enhance patient safety and comfort, boosting their adoption. The growing awareness about early diagnosis and intervention for brain-related conditions, coupled with improved healthcare infrastructure and increased healthcare spending, particularly in developed regions, further propels the intracranial pressure monitoring demand.
Invasive holds the largest share of the industry
The demand for invasive technology in the market is driven by its high accuracy and reliability in critical care settings. Pioneering the many intracranial pressure monitoring market recent developments, invasive technology is essential for managing severe traumatic brain injuries, hydrocephalus, and other neurological conditions requiring precise pressure measurements. Additionally, advancements in invasive monitoring devices have enhanced safety and ease of use, further boosting their adoption. The ability to provide continuous, real-time data critical for timely clinical interventions also drives the demand for invasive ICP monitoring technologies, thereby creating a positive market outlook across the globe.
Intraventricular represents the leading market segment
The demand for intraventricular monitoring in the market is driven by its superior accuracy and ability to both monitor and drain cerebrospinal fluid (CSF), making it crucial for managing severe traumatic brain injuries and hydrocephalus. This method provides continuous, real-time pressure data and therapeutic intervention capabilities, essential for critical care. Additionally, the increasing prevalence of neurological disorders and the need for precise intracranial pressure management in intensive care units further boost the demand for intraventricular monitoring.
Traumatic Brain Injury exhibits a clear dominance in the market
The demand for intracranial pressure (ICP) monitoring in traumatic brain injury (TBI) is driven by the need for precise, real-time pressure data to prevent secondary brain damage. Early and accurate ICP monitoring is crucial for guiding treatment decisions, reducing mortality rates, and improving patient outcomes. The high prevalence of TBIs, particularly from accidents and sports injuries, coupled with advancements in monitoring technology and increased awareness among healthcare providers, are further propelling the demand for ICP monitoring in this application.
Hospitals dominates the market
The demand for intracranial pressure (ICP) monitoring in hospitals is driven by the high incidence of traumatic brain injuries, strokes, and neurological disorders requiring critical care. Hospitals are equipped with advanced medical infrastructure and specialized staff capable of utilizing ICP monitoring technologies effectively. The emphasis on early diagnosis and intervention, coupled with the need for continuous, accurate monitoring in intensive care units, further boosts demand. Additionally, hospitals' ability to integrate the latest advancements in ICP monitoring ensures better patient outcomes and drives the intracranial pressure monitoring market growth.
North America leads the market, accounting for the largest intracranial pressure monitoring market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for intracranial pressure monitoring.
In North America, the intracranial pressure monitoring market is driven by the high prevalence of traumatic brain injuries and neurological disorders, advanced healthcare infrastructure, and significant healthcare expenditure. According to a study by the University of Pennsylvania, each year, an estimated 2 million Americans suffer some form of traumatic brain injury. Brain injury is suffered by someone in America, usually a young person, every 15 seconds. Each year, approximately 100,000 people die from TBI and 500,000 more are permanently disabled. 80,000 people experience the onset of long-term disability following a severe brain injury annually. Approximately 5.3 million Americans, more than 2% of the US population - are living with a disability that results from TBI. The cost of treating, rehabilitating, and caring for the victims of traumatic brain injury costs the U.S. approximately $30 billion each year. The region's strong adoption of innovative medical technologies and increased awareness of early diagnosis and intervention for brain-related conditions further boost demand. Additionally, the presence of leading medical device manufacturers and ongoing research and development activities contribute to the market's growth in North America.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)